|
⚲
|
| Keyboard |
| Grogan Donna Roy
✚
|
|
|---|---|
| CIK # | 0001788455 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001788455] | |
| 4 | [0001788455] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| C4 Therapeutics Inc | |
| Grogan Donna Roy | |
| Momenta Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-01-02 | Grant | 7,513 | $1.93 | 14,500 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-10-01 | Grant | 6,740 | $2.15 | 14,491 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-07-01 | Grant | 9,609 | $1.51 | 14,510 |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2025-06-18 | Grant | 35,500 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-04-01 | Grant | 9,581 | $1.44 | 13,797 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-01-02 | Grant | 3,757 | $3.66 | 13,751 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-10-01 | Grant | 2,474 | $5.56 | 13,755 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-07-01 | Grant | 2,836 | $4.85 | 13,755 |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2024-06-20 | Grant | 32,500 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-04-01 | Grant | 1,697 | $8.10 | 13,746 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-01-02 | Grant | 2,108 | $6.52 | 13,744 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2023-10-02 | Grant | 8,089 | $1.70 | 13,751 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2023-07-03 | Grant | 4,858 | $2.83 | 13,748 |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2023-06-15 | Grant | 26,000 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2023-04-03 | Grant | 4,298 | $3.20 | 13,754 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2023-01-03 | Grant | 1,763 | $6.38 | 11,248 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2022-10-03 | Grant | 819 | $8.69 | 7,117 |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2022-07-29 | Grant | 41,200 | $0.00 | |
|
Momenta Pharmaceuticals Inc MNTA
Stock Option (Right to Buy) · derivative
|
2020-10-01 | Disposed to issuer | 25,000 | ||
|
Momenta Pharmaceuticals Inc MNTA
Stock Option (Right to Buy) · derivative
|
2020-10-01 | Disposed to issuer | 50,000 | ||
| showing 20 of 22 most recent transactions | |||||